Pathophysiology of sepsis (Q80210901)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17456750 AND SRC:MED&resulttype=core&format=json

29 December 2019

review article

1 reference

title

Pathophysiology of sepsis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17456750 AND SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17456750 AND SRC:MED&resulttype=core&format=json

29 December 2019

publication date

1 May 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17456750 AND SRC:MED&resulttype=core&format=json

The American Journal of Pathology

29 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17456750 AND SRC:MED&resulttype=core&format=json

29 December 2019

volume

170

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17456750 AND SRC:MED&resulttype=core&format=json

29 December 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17456750 AND SRC:MED&resulttype=core&format=json

29 December 2019

page(s)

1435-1444

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17456750 AND SRC:MED&resulttype=core&format=json

HMG-1 as a late mediator of endotoxin lethality in mice

29 December 2019

cites work

1 reference

12 December 2020

Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction

1 reference

12 December 2020

Comparison of the mortality and inflammatory response of two models of sepsis: lipopolysaccharide vs. cecal ligation and puncture

1 reference

12 December 2020

Coagulation abnormalities in acute lung injury and sepsis

1 reference

12 December 2020

Impaired ex vivo lipopolysaccharide-stimulated whole blood tumor necrosis factor production may identify "septic" intensive care unit patients

1 reference

12 December 2020

Immunodeficiency diseases caused by defects in phagocytes

1 reference

12 December 2020

Cytopathic hypoxia. Mitochondrial dysfunction as mechanism contributing to organ dysfunction in sepsis

1 reference

12 December 2020

Efficacy and safety of recombinant human activated protein C for severe sepsis

1 reference

12 December 2020

Apoptosis in sepsis: a new target for therapeutic exploration

1 reference

12 December 2020

Lenercept (p55 tumor necrosis factor receptor fusion protein) in severe sepsis and early septic shock: a randomized, double-blind, placebo-controlled, multicenter phase III trial with 1,342 patients

1 reference

12 December 2020

Randomized, placebo-controlled trial of the anti-tumor necrosis factor antibody fragment afelimomab in hyperinflammatory response during severe sepsis: The RAMSES Study

1 reference

12 December 2020

Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care

1 reference

12 December 2020

Early trauma polymorphonuclear neutrophil responses to chemokines are associated with development of sepsis, pneumonia, and organ failure

1 reference

12 December 2020

Molecular mechanisms of bacteria induced apoptosis.

1 reference

12 December 2020

Role of apoptosis in Pseudomonas aeruginosa pneumonia

1 reference

12 December 2020

Intensive insulin therapy in critically ill patients

1 reference

12 December 2020

Early goal-directed therapy in the treatment of severe sepsis and septic shock

1 reference

12 December 2020

Six at six: interleukin-6 measured 6 h after the initiation of sepsis predicts mortality over 3 days

1 reference

12 December 2020

Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock

1 reference

12 December 2020

Cytokine therapeutics for the treatment of sepsis: why has nothing worked?

1 reference

12 December 2020

Multicenter, double-blind, placebo-controlled study of the use of filgrastim in patients hospitalized with pneumonia and severe sepsis

1 reference

12 December 2020

Impaired production of interferon-gamma and tumor necrosis factor-alpha but not of interleukin 10 in whole blood of patients with sepsis

1 reference

12 December 2020

2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference

1 reference

12 December 2020

The epidemiology of sepsis in the United States from 1979 through 2000

1 reference

12 December 2020

Adoptive transfer of apoptotic splenocytes worsens survival, whereas adoptive transfer of necrotic splenocytes improves survival in sepsis

1 reference

12 December 2020

Such stuff as dreams are made on: mediator-directed therapy in sepsis

1 reference

12 December 2020

Lower levels of whole blood LPS-stimulated cytokine release are associated with poorer clinical outcomes in surgical ICU patients.

1 reference

12 December 2020

Inflammatory status in sepsis alters efficacy of interleukin-18 binding protein therapy

1 reference

12 December 2020

Development of a sensitive microarray immunoassay and comparison with standard enzyme-linked immunoassay for cytokine analysis

1 reference

12 December 2020

Neutrophil chemotaxis and receptor expression in clinical septic shock

1 reference

12 December 2020

Delayed neutrophil apoptosis in sepsis is associated with maintenance of mitochondrial transmembrane potential and reduced caspase-9 activity

1 reference

12 December 2020

How does blood glucose control with insulin save lives in intensive care?

1 reference

12 December 2020

Use of corticosteroid therapy in patients with sepsis and septic shock: an evidence-based review

1 reference

12 December 2020

Adjunctive therapies in sepsis: an evidence-based review

1 reference

12 December 2020

Efficacy and safety of the monoclonal anti-tumor necrosis factor antibody F(ab')2 fragment afelimomab in patients with severe sepsis and elevated interleukin-6 levels

1 reference

12 December 2020

Acute inflammatory response to endotoxin in mice and humans

1 reference

12 December 2020

Leukocyte apoptosis and its significance in sepsis and shock

1 reference

12 December 2020

Reversing systemic inflammatory response syndrome with chemokine receptor pepducins

1 reference

12 December 2020

American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis

1 reference

12 December 2020

Enhanced neutrophil migratory activity following major blunt trauma.

1 reference

12 December 2020

Intensive insulin therapy protects the endothelium of critically ill patients

1 reference

12 December 2020

Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death

1 reference

12 December 2020

Animal models of sepsis: setting the stage

1 reference

12 December 2020

The interactions between inflammation and coagulation

1 reference

12 December 2020

An essential role for complement C5a in the pathogenesis of septic cardiac dysfunction

1 reference

12 December 2020

Pathobiology of sepsis: are we still asking the same questions?

1 reference

12 December 2020

Implementation and outcomes of the Multiple Urgent Sepsis Therapies (MUST) protocol

1 reference

12 December 2020

Molgramostim (GM-CSF) associated with antibiotic treatment in nontraumatic abdominal sepsis: a randomized, double-blind, placebo-controlled clinical trial.

1 reference

12 December 2020

Modulation of the triggering receptor expressed on the myeloid cell type 1 pathway in murine septic shock

1 reference

12 December 2020

Inflammation and the activated protein C anticoagulant pathway

1 reference

12 December 2020

The systemic inflammatory response syndrome

1 reference

12 December 2020

Vascular endothelial growth factor is an important determinant of sepsis morbidity and mortality

1 reference

12 December 2020

Safety and efficacy of affinity-purified, anti–tumor necrosis factor-α, ovine fab for injection (CytoFab) in severe sepsis*

1 reference

12 December 2020

Neutrophils in development of multiple organ failure in sepsis

1 reference

12 December 2020

Circulating cytokine/inhibitor profiles reshape the understanding of the SIRS/CARS continuum in sepsis and predict mortality.

1 reference

12 December 2020

Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition

1 reference

12 December 2020

Surviving sepsis--practice guidelines, marketing campaigns, and Eli Lilly

1 reference

12 December 2020

1 reference

12 December 2020

Evaluation of an intensive insulin protocol for septic patients in a medical intensive care unit

1 reference

12 December 2020

Tissue destruction by neutrophils

1 reference

12 December 2020

Defective IL-2 production in patients with severe burns and sepsis

1 reference

12 December 2020

Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease

1 reference

12 December 2020

Protein C, isolation and potential use in prevention of thrombosis

1 reference

12 December 2020

Acute in vivo effects of human recombinant tumor necrosis factor

1 reference

12 December 2020

Shock and tissue injury induced by recombinant human cachectin

1 reference

12 December 2020

Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin

1 reference

12 December 2020

Major injury leads to predominance of the T helper-2 lymphocyte phenotype and diminished interleukin-12 production associated with decreased resistance to infection

1 reference

12 December 2020

Interleukin-1 Blockade Attenuates Mediator Release and Dysregulation of the Hemostatic Mechanism During Human Sepsis

1 reference

12 December 2020

CDP571, a humanized antibody to human tumor necrosis factor-alpha

1 reference

12 December 2020

Endotoxin and tumour necrosis factor do not cause mortality from caecal ligation and puncture.

1 reference

12 December 2020

Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study Group.

1 reference

12 December 2020

Effect of interferon gamma on infection-related death in patients with severe injuries. A randomized, double-blind, placebo-controlled trial

1 reference

12 December 2020

Neutrophils, host defense, and inflammation: a double-edged sword

1 reference

12 December 2020

Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: a randomized, open-label, placebo-controlled multicenter trial

1 reference

12 December 2020

Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group

1 reference

12 December 2020

Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis. The CB0006 Sepsis Syndrome Study Group

1 reference

12 December 2020

Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group

1 reference

12 December 2020

Sir Isaac Newton, sepsis, SIRS, and CARS

1 reference

12 December 2020

Assessment of the safety and efficacy of the monoclonal anti-tumor necrosis factor antibody-fragment, MAK 195F, in patients with sepsis and septic shock: a multicenter, randomized, placebo-controlled, dose-ranging study.

1 reference

12 December 2020

INTERSEPT: an international, multicenter, placebo-controlled trial of monoclonal antibody to human tumor necrosis factor-alpha in patients with sepsis. International Sepsis Trial Study Group.

1 reference

12 December 2020

p55 Tumor necrosis factor receptor fusion protein in the treatment of patients with severe sepsis and septic shock. A randomized controlled multicenter trial. Ro 45-2081 Study Group

1 reference

12 December 2020

Monocyte deactivation in septic patients: restoration by IFN-gamma treatment

1 reference

12 December 2020

Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group

1 reference

12 December 2020

Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock. NORASEPT II Study Group

1 reference

12 December 2020

Effect of a chimeric antibody to tumor necrosis factor-alpha on cytokine and physiologic responses in patients with severe sepsis--a randomized, clinical trial

1 reference

12 December 2020

10.2353/AJPATH.2007.060872

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17456750 AND SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17456750 AND SRC:MED&resulttype=core&format=json

29 December 2019

PubMed publication ID

17456750

1 reference